Pediatric rheumatology

Genotype–phenotype correlations in pediatric CAPS with predominantly low-penetrance NLRP3 variants among Turkish patients in Germany and Turkey: beyond borders

Pediatr Rheumatol Online JPublished Retrospective cohort study

Authors' conclusion

These findings suggest that Turkish-origin pediatric CAPS patients living in Turkey, including those with similar VUS/Q703K genotypes, may experience higher disease activity and greater treatment dependence than their German counterparts.

Study context

Population
Turkish-origin pediatric patients meeting CAPS criteria, centres in Germany and Turkey; median age at onset 1 year, at diagnosis 4 years
Participants
51 patients
Exposure
Turkish-origin pediatric CAPS patients living in Turkey vs Germany
  • Turkishn = 23
  • Germann = 28reference
Outcome
Phenotypic and genotypic features (demographic, genetic, clinical, treatment data; disease activity by PGA and PPGA)
Methodological detailsmulticentre
  • Multicentre

Main finding

As reported in the abstract

  • Turkish cohort had more pathogenic mutations and more severe phenotypes; German cohort predominantly VUS/Q703K variants with mild phenotype
  • Diagnostic delay and attack duration longer in Turkish cohort
  • Urticarial rash, fatigue, thoracic pain, fever and aphthous ulcers more frequent in Turkish cohort; diarrhea, lymphadenopathy and infection-triggered attacks predominated in German cohort
  • Baseline disease activity higher in Turkish cohort; most achieved remission at last visit under therapy (mainly above-standard doses of Canakinumab), whereas over half of German cohort reached remission without treatment

Observational data: associations, not effects.

Further findings

VUS/Q703K subgroup

Turkish cohort: older age at diagnosis, longer diagnostic delay, more moderate phenotypes, higher baseline disease activity; German cohort: milder phenotypes, infection-triggered attacks, gastrointestinal involvement
Turkish cohort received Canakinumab or Anakinra more frequently, often above-standard doses, frequently complete remission under therapy; German cohort more often remission without treatment
Non-remission and partial remission observed exclusively in Turkish cohort

Original publication

Genotype–phenotype correlations in pediatric CAPS with predominantly low-penetrance NLRP3 variants among Turkish patients in Germany and Turkey: beyond borders. Pediatr Rheumatol Online J. Published 11 April 2026. doi:10.1186/s12969-026-01214-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.